Regeneron other research news

REGN researchers reported in Science the use of soluble alpha receptor (sRa) components to create "designer" cytokines that activate a desired cell type expressing a specific cell surface marker.

Scientists tested sRa-monoclonal antibody complexes, combining sRa components for interleukin-6 and ciliary neutrophic factor ( CNTF) and MAbs that recognize specific cell surface markers to selectively target various cell types, including cells expressing CD34 and CD45. ...